Literature DB >> 12100035

Fractalkine expression on human renal tubular epithelial cells: potential role in mononuclear cell adhesion.

S J Chakravorty1, P Cockwell, J Girdlestone, C J Brooks, C O S Savage.   

Abstract

Fractalkine (CX3CL1) is a transmembrane molecule with a CX3C chemokine domain attached to an extracellular mucin stalk which can induce both adhesion and migration of leucocytes. Mononuclear cell infiltration at renal tubular sites and associated tubular epithelial cell damage are key events during acute renal inflammation following renal allograft transplantation. Using northern and Western blot analysis, we have demonstrated the expression of fractalkine message and protein by renal tubular epithelial cells in vitro. The expression was up-regulated by TNF-alpha, a key proinflammatory cytokine in acute rejection. Investigation of surface expression of fractalkine on cultured proximal tubular epithelial cells revealed only a subpopulation of positively staining cells. Immunohistochemistry revealed that only a proportion of tubules in renal allograft biopsies showed induction of fractalkine expression. Studies using a static model of adhesion demonstrated CX3CR1/fractalkine interactions accounted for 26% of monocytic THP-1 cell and 17% of peripheral blood natural killer cell adhesion to tubular epithelial cells, suggesting that fractalkine may have a functional role in leucocyte adhesion and retention, at selected tubular sites in acute renal inflammation. Thus, fractalkine blockade strategies could reduce mononuclear cell mediated tubular damage and improve graft survival following kidney transplantation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12100035      PMCID: PMC1906421          DOI: 10.1046/j.1365-2249.2002.01906.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  45 in total

1.  CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms.

Authors:  S Goda; T Imai; O Yoshie; O Yoneda; H Inoue; Y Nagano; T Okazaki; H Imai; E T Bloom; N Domae; H Umehara
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

2.  Activated platelets adherent to an intact endothelial cell monolayer bind flowing neutrophils and enable them to transfer to the endothelial surface.

Authors:  C M Kirton; G B Nash
Journal:  J Lab Clin Med       Date:  2000-10

3.  Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses.

Authors:  P Fraticelli; M Sironi; G Bianchi; D D'Ambrosio; C Albanesi; A Stoppacciaro; M Chieppa; P Allavena; L Ruco; G Girolomoni; F Sinigaglia; A Vecchi; A Mantovani
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

4.  Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation.

Authors:  E J Papadopoulos; C Sassetti; H Saeki; N Yamada; T Kawamura; D J Fitzhugh; M A Saraf; T Schall; A Blauvelt; S D Rosen; S T Hwang
Journal:  Eur J Immunol       Date:  1999-08       Impact factor: 5.532

5.  Fractalkine expression in human renal inflammation.

Authors:  Paul Cockwell; Srabasti J Chakravorty; John Girdlestone; Caroline O S Savage
Journal:  J Pathol       Date:  2002-01       Impact factor: 7.996

6.  The nucleotide sequence of a rat 18 S ribosomal ribonucleic acid gene and a proposal for the secondary structure of 18 S ribosomal ribonucleic acid.

Authors:  Y L Chan; R Gutell; H F Noller; I G Wool
Journal:  J Biol Chem       Date:  1984-01-10       Impact factor: 5.157

7.  Chemoattraction of T cells expressing CCR5, CXCR3 and CX3CR1 by proximal tubular epithelial cell chemokines.

Authors:  Paul Cockwell; Judith W Calderwood; Christopher J Brooks; Srabasti J Chakravorty; Caroline O S Savage
Journal:  Nephrol Dial Transplant       Date:  2002-05       Impact factor: 5.992

8.  A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection.

Authors:  L A Robinson; C Nataraj; D W Thomas; D N Howell; R Griffiths; V Bautch; D D Patel; L Feng; T M Coffman
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

9.  Unique role of the chemokine domain of fractalkine in cell capture. Kinetics of receptor dissociation correlate with cell adhesion.

Authors:  C A Haskell; M D Cleary; I F Charo
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

10.  Upregulation of fractalkine in human crescentic glomerulonephritis.

Authors:  K Furuichi; T Wada; Y Iwata; N Sakai; K Yoshimoto; M Shimizu; K Kobayashi; K Takasawa; H Kida; S Takeda; K Matsushima; H Yokoyama
Journal:  Nephron       Date:  2001-04       Impact factor: 2.847

View more
  12 in total

1.  Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P.

Authors:  Lia M Haynes; Les P Jones; Albert Barskey; Larry J Anderson; Ralph A Tripp
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 2.  New molecular insights in diabetic nephropathy.

Authors:  Ionel Alexandru Checheriţă; Gina Manda; Mihai Eugen Hinescu; Ileana Peride; Andrei Niculae; Ştefana Bîlha; Angelica Grămăticu; Luminiţa Voroneanu; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2016-01-12       Impact factor: 2.370

3.  Associations of fractalkine receptor (CX3CR1) and CCR5 gene variants with hypertension, diabetes and atherosclerosis in chronic renal failure patients undergoing hemodialysis.

Authors:  Binnur Bagci; Gokhan Bagci; Can Huzmeli; Ilhan Sezgin; Ozturk Ozdemir
Journal:  Int Urol Nephrol       Date:  2016-04-27       Impact factor: 2.370

Review 4.  Non-coding RNAs in epithelial immunity to Cryptosporidium infection.

Authors:  Rui Zhou; Yaoyu Feng; Xian-Ming Chen
Journal:  Parasitology       Date:  2014-05-14       Impact factor: 3.234

5.  Fractalkine and other chemokines in primary biliary cirrhosis.

Authors:  Shinji Shimoda; Carlo Selmi; M Eric Gershwin
Journal:  Int J Hepatol       Date:  2011-08-09

Review 6.  CX3CL1/CX3CR1 Axis, as the Therapeutic Potential in Renal Diseases: Friend or Foe?

Authors:  Quan Zhuang; Ke Cheng; Yingzi Ming
Journal:  Curr Gene Ther       Date:  2017       Impact factor: 4.391

7.  The miR-561-5p/CX3CL1 Signaling Axis Regulates Pulmonary Metastasis in Hepatocellular Carcinoma Involving CX3CR1+ Natural Killer Cells Infiltration.

Authors:  Er-Bao Chen; Zheng-Jun Zhou; Kun Xiao; Gui-Qi Zhu; Yi Yang; Biao Wang; Shao-Lai Zhou; Qing Chen; Dan Yin; Zheng Wang; Ying-Hong Shi; Dong-Mei Gao; Jie Chen; Yan Zhao; Wei-Zhong Wu; Jia Fan; Jian Zhou; Zhi Dai
Journal:  Theranostics       Date:  2019-07-09       Impact factor: 11.556

8.  Histone deacetylases and NF-kB signaling coordinate expression of CX3CL1 in epithelial cells in response to microbial challenge by suppressing miR-424 and miR-503.

Authors:  Rui Zhou; Ai-Yu Gong; Dongqing Chen; Ryan E Miller; Alex N Eischeid; Xian-Ming Chen
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

9.  Association of chemokine receptor CX3CR1 V249I and T280M polymorphisms with chronic kidney disease.

Authors:  A K Yadav; V Kumar; V Jha
Journal:  Indian J Nephrol       Date:  2016 Jul-Aug

10.  Upregulation of KSRP by miR-27b provides IFN-γ-induced post-transcriptional regulation of CX3CL1 in liver epithelial cells.

Authors:  Zijie Xia; Yajing Lu; Xiaoqing Li; Tiebo Mao; Xian-Ming Chen; Rui Zhou
Journal:  Sci Rep       Date:  2015-12-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.